Related Experiment Video
Updated: Jul 8, 2026

Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
[Cardiovascular complications of alpha interferon]
Monika Le Corguillé1, Gilbert Pochmalicki, Claude Eugène
1Service d'hépatogastroentérologie, Centre hospitalier intercommunal de Poissy-Saint-Germain, Poissy. monika.lecorguille@ch-provins.fr
Abstract:
Interferon-alpha is a biological response modifier with antiviral and tumoral effect that is used in the treatment of chronic viral hepatitis. Cardiovascular complications occurred in clinical trials of interferon. The most common presentations of cardio toxicity were cardiac arrhythmia, dilated cardiomyopathy, atrial extrasystole and symptoms of ischemic heart disease, including myocardial infarction and other effects less common and dangerous: low-level conduction impairment or reversible hypertension. The physiopathology of this cardiotoxicity remains unknown, but rigorous cardiological monitoring of all patients receiving this treatment seems necessary.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hemodialysis II: Procedure and Complications
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Rheumatic Heart Disease I: Introduction
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Complications of Diabetes Mellitus